Shineco, Inc. (SISI)
USD 0.76
(-5.0%)
USD 0.76
(-5.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 | 1.58 Million USD | 389.67% |
| 2023 | 324.4 Thousand USD | -98.27% |
| 2022 | 18.71 Million USD | 1314.44% |
| 2021 | 1.32 Million USD | -26.47% |
| 2020 | 1.79 Million USD | -18.76% |
| 2019 | 2.21 Million USD | -6.3% |
| 2018 | 2.36 Million USD | 0.78% |
| 2017 | 2.34 Million USD | -49.08% |
| 2016 | 4.6 Million USD | -44.5% |
| 2015 | 8.3 Million USD | 50.91% |
| 2014 | 5.5 Million USD | -27.34% |
| 2013 | 7.57 Million USD | 0.0% |
| 2006 | 2.3 Million USD | 0.0% |
| 2005 | 2.3 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q4 | 1.58 Million USD | -88.81% |
| 2024 Q3 | 14.19 Million USD | 613.85% |
| 2024 Q2 | 1.98 Million USD | -6.11% |
| 2024 Q1 | 2.11 Million USD | 552.96% |
| 2023 Q2 | 18.18 Million USD | 0.71% |
| 2023 Q4 | 324.4 Thousand USD | -98.29% |
| 2023 Q3 | 18.99 Million USD | 4.45% |
| 2023 FY | 324.4 Thousand USD | -98.27% |
| 2023 Q1 | 18.05 Million USD | -3.54% |
| 2022 Q3 | 21.06 Million USD | 0.24% |
| 2022 Q1 | 20.35 Million USD | 1438.16% |
| 2022 FY | 18.71 Million USD | 1314.44% |
| 2022 Q2 | 21.01 Million USD | 3.23% |
| 2022 Q4 | 18.71 Million USD | -11.13% |
| 2021 Q2 | 3.01 Million USD | -21.55% |
| 2021 Q3 | 2.36 Million USD | -21.64% |
| 2021 FY | 1.32 Million USD | -26.47% |
| 2021 Q4 | 1.32 Million USD | -44.0% |
| 2021 Q1 | 3.84 Million USD | 113.57% |
| 2020 FY | 1.79 Million USD | -18.76% |
| 2020 Q3 | 1.69 Million USD | -35.08% |
| 2020 Q4 | 1.79 Million USD | 5.89% |
| 2020 Q1 | 1.98 Million USD | -10.24% |
| 2020 Q2 | 2.61 Million USD | 31.64% |
| 2019 Q1 | 2.3 Million USD | -2.56% |
| 2019 Q2 | 2.37 Million USD | 3.08% |
| 2019 Q3 | 2.38 Million USD | 0.49% |
| 2019 Q4 | 2.21 Million USD | -7.17% |
| 2019 FY | 2.21 Million USD | -6.3% |
| 2018 Q2 | 2.5 Million USD | 9.38% |
| 2018 Q3 | 2.76 Million USD | 10.51% |
| 2018 Q4 | 2.36 Million USD | -14.49% |
| 2018 FY | 2.36 Million USD | 0.78% |
| 2018 Q1 | 2.28 Million USD | -2.5% |
| 2017 FY | 2.34 Million USD | -49.08% |
| 2017 Q4 | 2.34 Million USD | 28.78% |
| 2017 Q3 | 1.82 Million USD | -4.82% |
| 2017 Q2 | 1.91 Million USD | -52.64% |
| 2017 Q1 | 4.04 Million USD | -12.29% |
| 2016 Q4 | 4.6 Million USD | -32.45% |
| 2016 Q3 | 6.82 Million USD | -0.1% |
| 2016 Q2 | 6.82 Million USD | -3.58% |
| 2016 Q1 | 7.08 Million USD | -14.69% |
| 2016 FY | 4.6 Million USD | -44.5% |
| 2015 Q2 | 6.76 Million USD | 0.0% |
| 2015 Q4 | 8.3 Million USD | 0.31% |
| 2015 Q3 | 8.27 Million USD | 22.39% |
| 2015 Q1 | - USD | -100.0% |
| 2015 FY | 8.3 Million USD | 50.91% |
| 2014 Q3 | 7.05 Million USD | 0.0% |
| 2014 Q1 | - USD | -100.0% |
| 2014 FY | 5.5 Million USD | -27.34% |
| 2014 Q4 | 5.5 Million USD | -22.01% |
| 2013 FY | 7.57 Million USD | 0.0% |
| 2013 Q4 | 7.57 Million USD | 0.0% |
| 2007 Q2 | 2.04 Million USD | -11.33% |
| 2007 Q3 | - USD | -100.0% |
| 2007 Q1 | 2.3 Million USD | 0.0% |
| 2006 FY | 2.3 Million USD | 0.0% |
| 2006 Q3 | 2.01 Million USD | 0.0% |
| 2006 Q1 | 2.28 Million USD | 0.0% |
| 2005 FY | 2.3 Million USD | 0.0% |
| 2005 Q3 | 2.42 Million USD | 5.09% |
| 2005 Q2 | 2.3 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Cosmos Health Inc. | 4.78 Million USD | 66.83% |
| Safety Shot Inc | 1.86 Million USD | 15.036% |
| Bright Green Corporation | - USD | -Infinity% |
| Embecta Corp. | 152.1 Million USD | 98.956% |
| ANI Pharmaceuticals, Inc. | 111.19 Million USD | 98.571% |
| Aquestive Therapeutics, Inc. | 6.76 Million USD | 76.532% |
| Collegium Pharmaceutical, Inc. | 32.33 Million USD | 95.087% |
| Dynavax Technologies Corporation | 53.29 Million USD | 97.019% |
| Esperion Therapeutics, Inc. | 65.62 Million USD | 97.579% |
| Intra-Cellular Therapies, Inc. | 11.64 Million USD | 86.361% |
| Pacira BioSciences, Inc. | 104.35 Million USD | 98.478% |
| PainReform Ltd. | - USD | -Infinity% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | 72.3% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | 72.3% |
| SCYNEXIS, Inc. | - USD | -Infinity% |
| China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | -96.173% |
| Journey Medical Corporation | 10.2 Million USD | 84.435% |
| Alpha Teknova, Inc. | 11.59 Million USD | 86.299% |
| Procaps Group, S.A. | 96.83 Million USD | 98.36% |
| Theratechnologies Inc. | 6.06 Million USD | 73.813% |
| Harrow Health, Inc. | 10.86 Million USD | 85.382% |
| Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | 41.577% |
| Biofrontera Inc. | 10.9 Million USD | 85.437% |
| DURECT Corporation | 2.21 Million USD | 28.413% |
| Supernus Pharmaceuticals, Inc. | 77.4 Million USD | 97.948% |
| Cronos Group Inc. | 30.33 Million USD | 94.764% |
| OptiNose, Inc. | 8.05 Million USD | 80.272% |
| Ironwood Pharmaceuticals, Inc. | 1.00 USD | -158852400.0% |
| Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
| RedHill Biopharma Ltd. | 5.69 Million USD | 72.126% |
| Organogenesis Holdings Inc. | 28.25 Million USD | 94.377% |
| Guardion Health Sciences, Inc. | 2.67 Million USD | 40.663% |
| Cumberland Pharmaceuticals Inc. | 4.6 Million USD | 65.537% |
| Radius Health, Inc. | 278.64 Million USD | 99.43% |
| Universe Pharmaceuticals INC | 3.34 Million USD | 52.486% |
| ProPhase Labs, Inc. | 3.84 Million USD | 58.643% |
| Phibro Animal Health Corporation | 265.91 Million USD | 99.403% |
| Procaps Group S.A. | 96.83 Million USD | 98.36% |
| Alvotech | 74.43 Million USD | 97.866% |
| TherapeuticsMD, Inc. | - USD | -Infinity% |
| Viatris Inc. | 3.46 Billion USD | 99.954% |
| Rockwell Medical, Inc. | 5.87 Million USD | 72.943% |
| Aytu BioPharma, Inc. | 12.63 Million USD | 87.426% |
| SIGA Technologies, Inc. | 64.21 Million USD | 97.526% |
| Tilray Brands, Inc. | 252.08 Million USD | 99.37% |
| Lifecore Biomedical, Inc. | 39.97 Million USD | 96.027% |
| PetIQ, Inc. | 159.3 Million USD | 99.003% |
| Regencell Bioscience Holdings Limited | -152.77 Thousand USD | 1139.76% |
| Incannex Healthcare Limited | -10.01 Million USD | 115.861% |
| Neurocrine Biosciences, Inc. | 38.3 Million USD | 95.852% |
| Alimera Sciences, Inc. | 1.87 Million USD | 15.459% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Assertio Holdings, Inc. | 37.68 Million USD | 95.785% |
| Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Petros Pharmaceuticals, Inc. | 1.61 Million USD | 1.358% |
| Clever Leaves Holdings Inc. | 4.48 Million USD | 64.566% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -524.538% |
| Avadel Pharmaceuticals plc | 10.38 Million USD | 84.696% |
| Hempacco Co., Inc. | 2.54 Million USD | 37.524% |
| Talphera, Inc. | - USD | -Infinity% |
| Alvotech | 74.43 Million USD | 97.866% |
| Eagle Pharmaceuticals, Inc. | 47.79 Million USD | 96.676% |
| Lantheus Holdings, Inc. | 64.02 Million USD | 97.519% |
| Currenc Group, Inc. | 732.91 Thousand USD | -116.742% |
| Kamada Ltd. | 87.74 Million USD | 98.19% |
| Indivior PLC | 141.79 Million USD | 98.88% |
| Evoke Pharma, Inc. | 481.84 Thousand USD | -229.679% |
| Flora Growth Corp. | 8.5 Million USD | 81.329% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -524.538% |
| Evolus, Inc. | 10.99 Million USD | 85.556% |
| HUTCHMED (China) Limited | 50.25 Million USD | 96.839% |
| Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | 98.499% |
| Akanda Corp. | 1.28 Million USD | -23.439% |